The Manila Times

Driven by Dual Engines of AI and New Energy, Han’s Laser Revenue Topped USD 2.67 Billion with Nearly Doubled NPAT (excl. NRGL)

On April 17th, Han’s Laser (002008.SZ) released its 2025 annual report. The report indicates that Han’s Laser exceeded annual ...
The Manila Times

Ractigen Therapeutics Presents Positive Phase I Data for RAG-17 in SOD1-ALS at the 2026 AAN Annual Meeting, Demonstrating 81% Reduction in Neurofilament Light C…

Single intrathecal dose of SCAD-siRNA therapeutic RAG-17 yields favorable safety profile and profound, durable biomarker ...